跳至主要内容
临床试验/ISRCTN11447662
ISRCTN11447662进行中(未招募)Unknown

A randomised controlled trial of regular MRI scans compared to standard care in patients with prostate cancer managed using active surveillance

Imperial College London0 个研究点目标入组 1,263 人开始时间: 2024年2月7日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
1,263

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Age 18 years or above (no upper limit)
  • 2. Patients with a prostate (either cis-male gender or trans-female gender with no prior androgen deprivation hormone use at all)
  • 3. Diagnostic bi-parametric or multiparametric MRI
  • 4. Diagnostic systematic biopsy +/- targeted biopsy
  • 5. A histological diagnosis of localised prostate cancer of low or intermediate risk

排除标准

  • 1. On active surveillance for greater than 9 months prior to the screening date
  • 2. Contraindication to MRI or gadolinium contrast
  • 3. Previous hip replacement to both hips
  • 4. Contraindication to performing a biopsy guided by a transrectal ultrasound probe

研究者

相似试验